← Back to Search

Individual-ESI plus Group-ESI for Autism Spectrum Disorder

N/A
Waitlist Available
Led By Nathan Call, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (12 months of age, prior to treatment), 15, 21, 24, and 36 months of age
Awards & highlights

Study Summary

This trial is testing two different interventions for children with autism, to see which one is more effective.

Eligible Conditions
  • Autism Spectrum Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (12 months of age, prior to treatment), 15, 21, 24, and 36 months of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (12 months of age, prior to treatment), 15, 21, 24, and 36 months of age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Autism Diagnostic Observation Schedule (ADOS) Score
Communication and Symbolic Behavior Scales (CSBS) Score
Mullen Scales of Early Learning (MSEL) Score
+1 more
Secondary outcome measures
Parent Report
Other outcome measures
Expressive Language Phase

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Individual-ESI plus Group-ESIExperimental Treatment2 Interventions
Infants 12 months of age at risk of developing ASD who are randomized to receive Individual-ESI intervention in addition to the Group-ESI intervention for 9 months.
Group II: Group-ESIActive Control1 Intervention
Infants 12 months of age at risk of developing ASD who are randomized to receive the Group-ESI intervention for 9 months.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,540 Total Patients Enrolled
23 Trials studying Autism Spectrum Disorder
21,632 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,074 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,319 Patients Enrolled for Autism Spectrum Disorder
Nathan Call, PhDPrincipal InvestigatorEmory University, Marcus Autism Center, Children's Healthcare of Atlanta
4 Previous Clinical Trials
432 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
432 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Changing Developmental Trajectories Through Early Treatment
Nathan A. Call 2013. "Changing Developmental Trajectories Through Early Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01985022.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top